Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/06/2023 | IOVANCE BIOTHERAPEUTICS, INC. | IOVA | Grant | Deferred Restricted Stock Unit | 52k | $0.00 | $0 | | 06/06/2023 |
05/25/2023 | Passage BIO, Inc. | PASG | Grant | Director Stock Option (Right to Buy) | 24k | $1.00 | $24k | | 05/25/2023 |
08/17/2022 | Turning Point Therapeutics, Inc. | TPTX | Disposition | Common Stock | 111k | $76.00 | $8.4M | | 08/17/2022 |
08/17/2022 | Turning Point Therapeutics, Inc. | TPTX | Disposition | Stock Option (right to buy) | 173.4k | $3.20 | $554.8k | | 08/17/2022 |
08/17/2022 | Turning Point Therapeutics, Inc. | TPTX | Disposition | Stock Option (right to buy) | 67.6k | $3.20 | $216.2k | | 08/17/2022 |
08/17/2022 | Turning Point Therapeutics, Inc. | TPTX | Disposition | Stock Option (right to buy) | 990k | $5.12 | $5.1M | | 08/17/2022 |
08/17/2022 | Turning Point Therapeutics, Inc. | TPTX | Disposition | Stock Option (right to buy) | 155.8k | $7.43 | $1.2M | | 08/17/2022 |
08/17/2022 | Turning Point Therapeutics, Inc. | TPTX | Disposition | Stock Option (right to buy) | 325k | $63.33 | $20.6M | | 08/17/2022 |
08/17/2022 | Turning Point Therapeutics, Inc. | TPTX | Disposition | Stock Option (right to buy) | 101.8k | $140.01 | $14.2M | | 08/17/2022 |
08/17/2022 | Turning Point Therapeutics, Inc. | TPTX | Disposition | Stock Option (right to buy) | 224.6k | $37.68 | $8.5M | | 08/17/2022 |
06/10/2022 | IOVANCE BIOTHERAPEUTICS, INC. | IOVA | Grant | Deferred Restricted Stock Unit | 51.2k | $0.00 | $0 | | 06/10/2022 |
05/26/2022 | Passage BIO, Inc. | PASG | Grant | Director Stock Option (Right to Buy) | 24k | $1.76 | $42.2k | | 05/26/2022 |
02/09/2022 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 3k | $36.30 | $107.8k | | 02/09/2022 |
02/09/2022 | Turning Point Therapeutics, Inc. | TPTX | Grant | Common Stock | 62.4k | $0.00 | $0 | | 02/09/2022 |
02/09/2022 | Turning Point Therapeutics, Inc. | TPTX | Grant | Stock Option (right to buy) | 224.6k | $37.68 | $8.5M | | 02/09/2022 |
05/27/2021 | Passage BIO, Inc. | PASG | Grant | Director Stock Option (Right to Buy) | 16.9k | $13.83 | $234k | | 05/27/2021 |
02/11/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 3.1k | $138.55 | $422.9k | | 02/09/2021 |
02/11/2021 | Turning Point Therapeutics, Inc. | TPTX | Exercise | Stock Option (right to buy) | 8.9k | $3.20 | $28.6k | | 02/09/2021 |
02/11/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 1.6k | $137.66 | $216.3k | | 02/09/2021 |
02/11/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 4.3k | $136.45 | $589.3k | | 02/09/2021 |
02/10/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 433 | $138.19 | $59.8k | | 02/09/2021 |
02/10/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 2.1k | $137.46 | $286.1k | | 02/09/2021 |
02/10/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 16.6k | $136.42 | $2.3M | | 02/09/2021 |
02/10/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 5.2k | $135.72 | $709.4k | | 02/09/2021 |
02/10/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 1k | $134.34 | $137.7k | | 02/09/2021 |
02/10/2021 | Turning Point Therapeutics, Inc. | TPTX | Exercise | Stock Option (right to buy) | 25.4k | $3.20 | $81.3k | | 02/09/2021 |
02/09/2021 | Turning Point Therapeutics, Inc. | TPTX | Exercise | Stock Option (right to buy) | 18k | $3.20 | $57.6k | | 02/09/2021 |
02/09/2021 | Turning Point Therapeutics, Inc. | TPTX | Exercise | Stock Option (right to buy) | 7.7k | $3.20 | $24.5k | | 02/09/2021 |
02/09/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 1.1k | $140.24 | $154.8k | | 02/09/2021 |
02/09/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 13.3k | $139.69 | $1.9M | | 02/09/2021 |
02/09/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 5k | $138.66 | $689k | | 02/09/2021 |
02/09/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 103 | $137.58 | $14.2k | | 02/09/2021 |
02/09/2021 | Turning Point Therapeutics, Inc. | TPTX | Sale | Common Stock | 6.2k | $136.29 | $845k | | 02/09/2021 |
02/08/2021 | Turning Point Therapeutics, Inc. | TPTX | Grant | Common Stock | 22.6k | $0.00 | $0 | | 02/08/2021 |
02/08/2021 | Turning Point Therapeutics, Inc. | TPTX | Grant | Stock Option (right to buy) | 101.8k | $140.01 | $14.2M | | 02/08/2021 |
|